Effect of the Glucagon‐like Peptide‐1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus

BACKGROUND: Exenatide extended release (ER) is a glucagon‐like peptide‐1 analogue that increases insulin secretion, inhibits glucagon secretion and induces satiation in humans with type 2 diabetes mellitus. The use of exenatide ER is safe and stimulates insulin secretion in healthy cats. OBJECTIVES:...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of veterinary internal medicine 2016-01, Vol.30 (1), p.92-100
Hauptverfasser:	Riederer, A., Zini, E., Salesov, E., Fracassi, F., Padrutt, I., Macha, K., Stöckle, T.M., Lutz, T.A., Reusch, C.E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animal Feed - analysis Animals Blood Glucose Cat Diseases - drug therapy Cats Diabetes Mellitus - drug therapy Diabetes Mellitus - veterinary Diet - veterinary Dietary Carbohydrates - pharmacology feline Female Hypoglycemia - chemically induced Hypoglycemia - veterinary Hypoglycemic Agents - adverse effects Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use incretin Insulin Glargine - therapeutic use Male metabolic control Peptides - adverse effects Peptides - pharmacology remission SMALL ANIMAL treatment Venoms - adverse effects Venoms - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!